S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Bear or bull market, this highly successful trader has shocking new forecast  (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Bear or bull market, this highly successful trader has shocking new forecast  (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Bear or bull market, this highly successful trader has shocking new forecast  (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
S&P 500   3,934.38
DOW   33,476.46
QQQ   282.04
Retirement Doesn't Have to Mean Golf Courses and Fishing — It Can Be Whatever You Want It to Be.
Bear or bull market, this highly successful trader has shocking new forecast  (Ad)
Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
Costco vs Amazon: an end of the year showdown
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
There Is Fundamental Value In Broadcom, And It Yields 3.35% 
Closing prices for crude oil, gold and other commodities
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Discount Retailers Could Make Good Bargain Stocks
How major US stock indexes fared Friday 12/9/2022
NASDAQ:NURO

NeuroMetrix - NURO Stock Forecast, Price & News

$1.58
0.00 (0.00%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.56
$1.64
50-Day Range
$1.41
$2.84
52-Week Range
$1.35
$7.41
Volume
33,233 shs
Average Volume
946,540 shs
Market Capitalization
$12.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NURO stock logo

About NeuroMetrix (NASDAQ:NURO) Stock

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Receive NURO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroMetrix and its competitors with MarketBeat's FREE daily newsletter.

NURO Stock News Headlines

StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO)
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com
NeuroMetrix Reports Q3 2022 Financial Results
See More Headlines
Receive NURO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroMetrix and its competitors with MarketBeat's FREE daily newsletter.

NURO Company Calendar

Last Earnings
10/20/2022
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
1/26/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NURO
Employees
23
Year Founded
1996

Profitability

Net Income
$-2,280,000.00
Pretax Margin
-57.45%

Debt

Sales & Book Value

Annual Sales
$8.25 million
Book Value
$3.48 per share

Miscellaneous

Free Float
7,214,000
Market Cap
$12.29 million
Optionable
Not Optionable
Beta
2.26

Social Links


Key Executives

  • Dr. Shai N. Gozani M.D. (Age 57)
    Ph.D., Founder, Chairman, CEO, Pres & Sec.
    Comp: $557.66k
  • Mr. Thomas T. HigginsMr. Thomas T. Higgins (Age 70)
    Sr. VP, CFO & Treasurer
    Comp: $414.38k
  • Dr. Xuan Kong Ph.D.
    Chief Data Scientist
  • Ms. Susan M. Bell R.N.
    Sr. VP of Population Health & Value Based Care













NURO Stock - Frequently Asked Questions

How have NURO shares performed in 2022?

NeuroMetrix's stock was trading at $5.02 on January 1st, 2022. Since then, NURO shares have decreased by 68.4% and is now trading at $1.5850.
View the best growth stocks for 2022 here
.

When is NeuroMetrix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 26th 2023.
View our NURO earnings forecast
.

How were NeuroMetrix's earnings last quarter?

NeuroMetrix, Inc. (NASDAQ:NURO) released its quarterly earnings data on Thursday, October, 20th. The medical device company reported ($0.23) earnings per share (EPS) for the quarter. The medical device company earned $1.97 million during the quarter. NeuroMetrix had a negative net margin of 57.46% and a negative trailing twelve-month return on equity of 20.37%.

When did NeuroMetrix's stock split?

Shares of NeuroMetrix reverse split before market open on Friday, May 12th 2017. The 1-8 reverse split was announced on Thursday, May 11th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 11th 2017. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

What is Shai N. Gozani's approval rating as NeuroMetrix's CEO?

10 employees have rated NeuroMetrix Chief Executive Officer Shai N. Gozani on Glassdoor.com. Shai N. Gozani has an approval rating of 57% among the company's employees. This puts Shai N. Gozani in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NeuroMetrix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroMetrix investors own include Merit Medical Systems (MMSI), Palatin Technologies (PTN), Citigroup (C), Salesforce (CRM), Nokia Oyj (NOK), Ampio Pharmaceuticals (AMPE), ReWalk Robotics (RWLK), Aurora Cannabis (ACB), Advanced Micro Devices (AMD) and Vaxart (VXRT).

What is NeuroMetrix's stock symbol?

NeuroMetrix trades on the NASDAQ under the ticker symbol "NURO."

Who are NeuroMetrix's major shareholders?

NeuroMetrix's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (4.51%), Citadel Advisors LLC (0.45%) and Renaissance Technologies LLC (0.36%). Insiders that own company stock include Shai Gozani, Thomas T Higgins and Topline Capital Management, Ll.
View institutional ownership trends
.

How do I buy shares of NeuroMetrix?

Shares of NURO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NeuroMetrix's stock price today?

One share of NURO stock can currently be purchased for approximately $1.59.

How much money does NeuroMetrix make?

NeuroMetrix (NASDAQ:NURO) has a market capitalization of $12.29 million and generates $8.25 million in revenue each year. The medical device company earns $-2,280,000.00 in net income (profit) each year or ($0.69) on an earnings per share basis.

How can I contact NeuroMetrix?

NeuroMetrix's mailing address is 4B GILL STREET WOBURN, MASSACHUSETTS MA, 01801. The official website for the company is www.neurometrix.com. The medical device company can be reached via phone at (781) 890-9989, via email at neurometrix.ir@neurometrix.com, or via fax at 302-636-5454.

This page (NASDAQ:NURO) was last updated on 12/10/2022 by MarketBeat.com Staff